SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
Cars.com
CARS
(Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -48.54%194M | -94.59%6M | -79.57%19M | 5.03%710M | -56.86%129M | 45.00%377M | 909.09%111M | -12.26%93M | 634.78%676M | 7,575.00%299M |
Net income from continuing operations | -218.25%-149M | 17.31%61M | 237.50%22M | -61.00%227M | -70.98%65M | -13.70%126M | -51.85%52M | -115.38%-16M | 1.93%582M | 83.61%224M |
Operating gains losses | -43.75%-23M | 41.67%-28M | 30.19%-37M | -318.39%-190M | 33.64%-73M | -200.00%-16M | -134.53%-48M | -226.19%-53M | 162.14%87M | -243.75%-110M |
Depreciation and amortization | 1.39%73M | 2.82%73M | -2.82%69M | 20.43%283M | -4.17%69M | 18.03%72M | 36.54%71M | 42.00%71M | 32.02%235M | 53.19%72M |
Deferred tax | 818.52%194M | 11.76%-15M | 65.12%-15M | -37.50%-154M | -644.44%-67M | -17.39%-27M | 70.18%-17M | -86.96%-43M | -833.33%-112M | -150.00%-9M |
Other non cash items | 86.67%-2M | -133.33%-2M | -36.36%7M | -82.05%7M | -61.54%5M | -266.67%-15M | -33.33%6M | 37.50%11M | -9.30%39M | -50.00%13M |
Change In working capital | -57.94%90M | -12,200.00%-121M | -127.88%-29M | 315.38%420M | 9.78%101M | 386.36%214M | 100.40%1M | 228.40%104M | 67.06%-195M | 146.23%92M |
-Change in receivables | -108.79%-8M | -325.00%-36M | -124.73%-23M | 193.62%176M | 45.45%-24M | 59.65%91M | 115.69%16M | 193.94%93M | 17.54%-188M | 58.10%-44M |
-Change in inventory | -39.13%56M | -305.26%-77M | 54.12%131M | 1,100.00%200M | -70.00%42M | 187.50%92M | 87.07%-19M | 288.89%85M | 95.67%-20M | 217.65%140M |
-Change in payables and accrued expense | -81.25%3M | 42.86%-12M | -12.07%-65M | -223.08%-32M | 138.46%31M | 124.24%16M | -275.00%-21M | -186.57%-58M | -77.78%26M | -38.10%13M |
-Change in other current assets | --0 | -33.33%2M | -20.00%-12M | 142.86%3M | -121.74%-5M | 400.00%15M | 113.04%3M | -400.00%-10M | 65.00%-7M | 866.67%23M |
-Change in other current liabilities | --39M | -90.91%2M | -900.00%-60M | 1,316.67%73M | 242.50%57M | --0 | 120.00%22M | -200.00%-6M | -700.00%-6M | -671.43%-40M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -48.54%194M | -94.59%6M | -79.57%19M | 5.03%710M | -56.86%129M | 45.00%377M | 909.09%111M | -12.26%93M | 634.78%676M | 7,575.00%299M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -187.50%-115M | -2.20%-93M | 40.84%-113M | 37.53%-273M | 143.75%49M | 80.58%-40M | -313.64%-91M | -96.91%-191M | -44.70%-437M | -433.33%-112M |
Capital expenditure reported | -8.80%-136M | -23.15%-133M | 6.31%-104M | -6.75%-506M | -51.40%-162M | -32.98%-125M | 3.57%-108M | 31.06%-111M | -3.04%-474M | 21.32%-107M |
Net PPE purchase and sale | 0.00%8M | 50.00%9M | -57.14%6M | 17.24%34M | -14.29%6M | -11.11%8M | 0.00%6M | 100.00%14M | -25.64%29M | -22.22%7M |
Net business purchase and sale | 127.27%3M | --13M | ---3M | 65.63%-11M | --0 | 81.97%-11M | --0 | --0 | -300.00%-32M | 200.00%1M |
Net investment purchase and sale | -92.50%6M | 30.00%26M | 93.55%-6M | 339.58%211M | 1,954.55%204M | 229.03%80M | -72.22%20M | -289.80%-93M | -51.52%48M | -110.00%-11M |
Net other investing changes | -50.00%4M | 11.11%-8M | -500.00%-6M | 87.50%-1M | 150.00%1M | 300.00%8M | -200.00%-9M | 80.00%-1M | -128.57%-8M | 33.33%-2M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -187.50%-115M | -2.20%-93M | 40.84%-113M | 37.53%-273M | 143.75%49M | 80.58%-40M | -313.64%-91M | -96.91%-191M | -44.70%-437M | -433.33%-112M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 81.64%-56M | 354.29%89M | 843.75%119M | -400.86%-581M | -301.79%-225M | -281.25%-305M | -418.18%-35M | -277.78%-16M | -154.46%-116M | -240.00%-56M |
Net issuance payments of debt | 71.28%-83M | 378.79%92M | 1,030.77%121M | 145.19%47M | 864.00%382M | -265.82%-289M | -353.85%-33M | -208.33%-13M | -146.64%-104M | -219.05%-50M |
Net common stock issuance | ---- | ---- | ---- | ---600M | ---- | ---- | ---- | ---- | --0 | ---- |
Cash dividends paid | 0.00%-2M | 0.00%-2M | 33.33%-2M | 0.00%-10M | 0.00%-3M | 0.00%-2M | 0.00%-2M | 0.00%-3M | 0.00%-10M | 0.00%-3M |
Net other financing activities | --29M | ---- | ---- | -800.00%-18M | -33.33%-4M | ---- | ---- | ---- | ---2M | ---3M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 81.64%-56M | 354.29%89M | 843.75%119M | -400.86%-581M | -301.79%-225M | -281.25%-305M | -418.18%-35M | -277.78%-16M | -154.46%-116M | -240.00%-56M |
Net cash flow | ||||||||||
Beginning cash position | 16.18%79M | -7.14%78M | -71.86%56M | 165.33%199M | 42.86%100M | -28.42%68M | -10.64%84M | 165.33%199M | -1.32%75M | 12.90%70M |
Current changes in cash | -28.13%23M | 113.33%2M | 121.93%25M | -217.07%-144M | -135.88%-47M | 223.08%32M | ---15M | -733.33%-114M | 4,000.00%123M | 773.33%131M |
Effect of exchange rate changes | --4M | 0.00%-1M | -200.00%-3M | 0.00%1M | 250.00%3M | --0 | -200.00%-1M | -200.00%-1M | 125.00%1M | 0.00%-2M |
End cash Position | 6.00%106M | 16.18%79M | -7.14%78M | -71.86%56M | -71.86%56M | 42.86%100M | -28.42%68M | -10.64%84M | 165.33%199M | 165.33%199M |
Free cash flow | -76.98%58M | -4,333.33%-127M | -372.22%-85M | 0.99%204M | -117.19%-33M | 51.81%252M | 102.97%3M | 67.27%-18M | 154.89%202M | 237.14%192M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |